Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-008-0066-0
Annals of Surgical Oncology 15:2653-2660 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Baliski, C.
Right arrow Articles by Anis, A. H.
PubMed
Right arrow Articles by Baliski, C.
Right arrow Articles by Anis, A. H.

Original Article

The Cost-Effectiveness of Three Strategies for the Surgical Treatment of Symptomatic Primary Hyperparathyroidism

Chris Baliski, MD, FRCPC1, Bohdan Nosyk, MA2, Adrienne Melck, MD1, Samuel Bugis, MD, FRCPC1, Frances Rosenberg, MD, PhD, FRCPC3 and Aslam H. Anis, PhD2,4

1 Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada
2 Department of Surgery, St. Paul’s Hospital, Vancouver, BC, Canada
3 Pathology and Laboratory Medicine, St. Paul’s Hospital, Vancouver, BC, Canada
4 Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC, Canada

Correspondence: Address correspondence and reprint requests to: Aslam H. Anis, PhD; E-mail: aslam.anis{at}ubc.ca

Introduction: Modern surgical approaches to the treatment of primary hyperparathyroidism [unilateral neck exploration (UNE) and minimally invasive parathyroidectomy (MIP)] have become commonplace in recent years. However, the cost-effectiveness of these strategies has been questioned since the effectiveness of the gold standard, bilateral neck exploration (BNE), is well established. The objective of our study was to determine the incremental cost effectiveness of UNE and MIP compared with BNE for treatment of primary hyperparathyroidism (HPT).

Methods: Patients presenting to a tertiary endocrine surgical center for treatment of HPT over a 38-month period were included in the study. The primary measure of effectiveness was the rate of postoperative complications (hypocalcemia and paresthesias) observed in our cohort. A decision analytic model was constructed to determine the incremental cost-effectiveness ratios (ICERs) of the UNE and MIP strategies compared with the BNE strategy. Deterministic and probabilistic sensitivity analyses were conducted to evaluate uncertainty around model-based estimates of costs and effectiveness.

Results: A total of 94 patients (56 BNEs, 19 UNEs, and 19 MIPs) provided estimates of mean costs (BNE = $4524, UNE = $4784, MIP = $4961) and success rates (BNE = 0.91, UNE = 0.86, MIP = 0.93) for each treatment arm. The gold standard BNE strategy dominated the UNE strategy (lower cost, higher effectiveness) under most model formulations. The MIP strategy had an ICER of $28,439 per complication avoided, which is likely to be above societal willingness to pay to avoid primarily minor postoperative complications.

Conclusion: Our results suggest that within our institution, and in several different model formulations, bilateral neck exploration remains the cost-effective strategy for the treatment of primary hyperparathyroidism.

Key Words: Cost-effectiveness • Primary hyperparathyroidism • Bilateral neck exploration • Unilateral neck exploration • Minimally invasive parathyroidectomy

Abbreviations: HPT, Primary hyperparathyroidism • BNE, Bilateral neck exploration • UNE, Unilateral neck exploration • MIP, Minimally invasive parathyroidectomy • IOPTH, Intraoperative parathyroid hormone (measurement) • SM, Sestamibi (scanning) • SPHCM, St Paul’s Hospital Cost Model • SPHHD, St. Paul’s Hospital Hyperparathyroidism Database • ICER, Incremental cost-effectiveness ratio • CEAC, Cost effectiveness acceptability curve







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.